A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of the Dihydropyrimidine Dehydrogenase (Dpd) Inhibitory Action of 5-Chloro-2,4-Dihydroxypyridine (Cdhp) as an S-1 Component.
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil; Tegafur
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 08 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2008 Status changed from recruiting to in progress.